EU MDR vs. US FDA: Key Regulatory Differences for Medical Device Manufacturers

EU MDR vs. US FDA: Key Regulatory Differences for Medical Device Manufacturers

For any medical device manufacturer serving the global market, understanding the regulatory frameworks of the European Union and the United States is essential. While both systems share the same ultimate goal — ensuring patient safety — the paths to compliance differ significantly.

Classification Systems

The EU MDR uses a four-tier classification based on risk: Class I (lowest), Class IIa, Class IIb, and Class III (highest). The US FDA classifies devices into Class I, II, and III, with Class III reserved for life-sustaining or implantable devices. The MDR's Class IIa and IIb allow more granular risk grading than the FDA's broader Class II category.

Approval Pathways

Under the FDA, most Class II devices follow the 510(k) premarket notification path, demonstrating substantial equivalence to an existing predicate device. Class III devices require the more rigorous Premarket Approval (PMA). The EU MDR, on the other hand, requires conformity assessment by a Notified Body for all devices above Class I, with a much heavier emphasis on clinical evaluation reports and post-market clinical follow-up.

Quality Management Systems

The FDA mandates compliance with 21 CFR Part 820 (Quality System Regulation), which is closely aligned with ISO 13485:2016. The EU MDR explicitly requires ISO 13485 certification as the baseline, but adds MDR-specific requirements including Person Responsible for Regulatory Compliance (PRRC) and more detailed technical documentation.

Post-Market Surveillance

One of the sharpest contrasts lies in post-market obligations. MDR requires manufacturers to prepare Periodic Safety Update Reports (PSURs) for Class IIa and above, and maintain a Post-Market Surveillance (PMS) Plan as part of the technical file. The FDA's post-market requirements, while robust, rely more on adverse event reporting through the MAUDE database rather than scheduled reporting cycles.

What This Means for Wehere Medical

With our products registered under both EU MDR and US FDA frameworks, we maintain a compliance-first approach across all product categories — from wound dressings and surgical drapes to interventional catheters and urological devices. Our three ISO 13485-certified factories and dedicated RA/QA team ensure that every shipment meets the documentary and labeling requirements of both regulatory systems, giving our global partners confidence in every procurement decision.

← Back to all news